SRRKScholar Rock Holding Corporation

$4B

Q3 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$8M

Operating Income

-$11M

Net Income

-$11M

EPS (Diluted)

$-0.44

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$10M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$109M

Total Liabilities

$7M

Stockholders' Equity

$102M

Cash & Equivalents

$104M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$8M	-$5M	-68.7%
Operating Income	-$11M	-$6M	-89.1%
Net Income	-$11M	-$6M	-81.5%

SRRK Q3 2018 Earnings — Scholar Rock Holding Corporation Revenue & Financial Results | Market Cap Arena